Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Elizabeth H. Baldini, MD, MPH


Radiation Oncology

Make an Appointment

Physician

  • Director, Radiation Oncology, Sarcoma Center
  • Institute Physician
  • Professor of Radiation Oncology, Harvard Medical School

Clinical Interests

  • Sarcomas
  • Thoracic malignancies

Contact Information

  • Appointments617-732-7948
  • Office Phone Number617-732-7948
  • Fax617-394-2668

Board Certification:

  • Radiation Oncology, 1993

Residency:

  • Harvard Joint Center for Radiation Therapy, Radiation Oncology
  • Harvard Joint Center for Radiation Therapy, Radiation Oncology, Chief Resident

Medical School:

  • Harvard Medical School

Recent Awards:

  • American Society of Therapeutic Radiation Oncology (ASTRO) Resident Essay Award 1992
  • Von Meyer Award for Clinical Research, Children's Hospital 1992
  • Harvard Medical School 50th Anniversary Program for Scholars in Medicine, Dana-Farber Cancer Institute Fellowship 2000

Research

Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. Cancer. 2021 Apr 28.
View in: PubMed

Clinical outcomes following high-dose-rate surface applicator brachytherapy for angiosarcoma of scalp and face. J Contemp Brachytherapy. 2021 Apr; 13(2):172-178.
View in: PubMed

Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054]. ESMO Open. 2021 Apr; 6(2):100097.
View in: PubMed

Mean Heart Dose Is an Inadequate Surrogate for Left Anterior Descending Coronary Artery Dose and the Risk of Major Adverse Cardiac Events in Lung Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys. 2021 Mar 10.
View in: PubMed

Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI). ESMO Open. 2021 Apr; 6(2):100054.
View in: PubMed

Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non-Small Cell Lung Cancer. JAMA Oncol. 2021 Feb 01; 7(2):206-219.
View in: PubMed

Statin Use, Heart Radiation Dose, and Survival in Locally Advanced Lung Cancer. Pract Radiat Oncol. 2021 Jan 18.
View in: PubMed

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial. JAMA Oncol. 2021 Jan 01; 7(1):e205865.
View in: PubMed

Management of meningeal solitary fibrous tumors/hemangiopericytoma; surgery alone or surgery plus postoperative radiotherapy? Acta Oncol. 2021 Jan; 60(1):35-41.
View in: PubMed

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2020 10; 21(10):1366-1377.
View in: PubMed

Angiosarcoma of the Scalp and Face: A Dosimetric Comparison of HDR Surface Applicator Brachytherapy and VMAT. Sarcoma. 2020; 2020:7615248.
View in: PubMed

Enhanced recovery after surgery pathway in patients with soft tissue sarcoma. Br J Surg. 2020 11; 107(12):1667-1672.
View in: PubMed

Extrameningeal solitary fibrous tumors-surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNet. Cancer. 2020 07 01; 126(13):3002-3012.
View in: PubMed

Regional Lymph Nodes in Scalp Angiosarcomas: The Hidden Harbinger of Doom? Ann Surg Oncol. 2020 Aug; 27(8):2589-2590.
View in: PubMed

Chemo-radiotherapy integration in unresectable locally advanced non-small-cell lung cancer: a review. Clin Transl Oncol. 2020 Oct; 22(10):1681-1686.
View in: PubMed

Racial Differences in Extremity Soft Tissue Sarcoma Treatment in a Universally Insured Population. J Surg Res. 2020 06; 250:125-134.
View in: PubMed

The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancer. Radiat Oncol. 2020 Jan 14; 15(1):14.
View in: PubMed

Screening populations at high risk for soft tissue sarcoma and surveillance following soft tissue sarcoma resection. J Surg Oncol. 2019 Oct; 120(5):882-890.
View in: PubMed

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting. Int J Cancer. 2020 04 01; 146(7):1917-1929.
View in: PubMed

Pediatric Radiation Therapy-When Too Much Is Not Enough. Int J Radiat Oncol Biol Phys. 2019 08 01; 104(5):963-966.
View in: PubMed

EGFR mutant locally advanced non-small cell lung cancer is at increased risk of brain metastasis. Clin Transl Radiat Oncol. 2019 Sep; 18:32-38.
View in: PubMed

Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer. J Am Coll Cardiol. 2019 06 18; 73(23):2976-2987.
View in: PubMed

A Comparison of Outcomes and Prognostic Features for Radiation-Associated Angiosarcoma of the Breast and Other Radiation-Associated Sarcomas. Int J Radiat Oncol Biol Phys. 2019 06 01; 104(2):425-435.
View in: PubMed

Reirradiation in Pediatric Patients With Recurrent Brain Tumors: A Last Hope, But One With Greatly Feared Consequences. Int J Radiat Oncol Biol Phys. 2019 01 01; 103(1):1-4.
View in: PubMed

Clinical Outcomes After Lung Stereotactic Body Radiation Therapy in Patients With or Without a Prior Lung Resection. Am J Clin Oncol. 2018 07; 41(7):695-701.
View in: PubMed

Neoadjuvant Chemotherapy, Concurrent Chemoradiation, and Adjuvant Chemotherapy for High-Risk Extremity Soft Tissue Sarcoma. Am Soc Clin Oncol Educ Book. 2018 May 23; 38:910-915.
View in: PubMed

Perioperative Management of Extremity Soft Tissue Sarcomas. J Clin Oncol. 2018 01 10; 36(2):118-124.
View in: PubMed

Amputation for Extremity Sarcoma: Contemporary Indications and Outcomes. Ann Surg Oncol. 2018 Feb; 25(2):394-403.
View in: PubMed

Radiation therapy in retroperitoneal sarcoma management. J Surg Oncol. 2018 Jan; 117(1):93-98.
View in: PubMed

Radiation toxicity in patients with collagen vascular disease and intrathoracic malignancy treated with modern radiation techniques. Radiother Oncol. 2017 11; 125(2):301-309.
View in: PubMed

Surgical Management of Primary Retroperitoneal Sarcomas: Rationale for Selective Organ Resection. Ann Surg Oncol. 2018 Jan; 25(1):98-106.
View in: PubMed

Retroperitoneal Sarcoma: Setting the Stage for Treatment Strategies Tailored to Histologic Subtype and Other Patient and Tumor Factors. Int J Radiat Oncol Biol Phys. 2017 10 01; 99(2):292-295.
View in: PubMed

Use of frailty to predict survival in elderly patients with early stage non-small-cell lung cancer treated with stereotactic body radiation therapy. J Geriatr Oncol. 2018 03; 9(2):130-137.
View in: PubMed

Ovary-Sparing Radiation Planning Techniques Can Achieve Ovarian Dose Reduction for Soft Tissue Sarcoma of the Buttock and Thigh. Sarcoma. 2017; 2017:2796925.
View in: PubMed

Cost-Effectiveness of Surveillance for Distant Recurrence in Extremity Soft Tissue Sarcoma. Ann Surg Oncol. 2017 Oct; 24(11):3264-3270.
View in: PubMed

The Conundrum of Retroperitoneal Liposarcoma-To Be More Aggressive or Less Aggressive? Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):269-270.
View in: PubMed

Localized Adult Ewing Sarcoma: Favorable Outcomes with Alternating Vincristine, Doxorubicin, Cyclophosphamide, and Ifosfamide, Etoposide (VDC/IE)-Based Multimodality Therapy. Oncologist. 2017 10; 22(10):1265-1270.
View in: PubMed

Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC. PLoS One. 2017; 12(4):e0174268.
View in: PubMed

Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):375-383.
View in: PubMed

Incidence and Adverse Prognostic Implications of Histopathologic Organ Invasion in Primary Retroperitoneal Sarcoma. J Am Coll Surg. 2017 May; 224(5):876-883.
View in: PubMed

Surveillance Imaging Patterns and Outcomes Following Radiation Therapy and Radical Resection for Localized Extremity and Trunk Soft Tissue Sarcoma. Ann Surg Oncol. 2017 Jun; 24(6):1588-1595.
View in: PubMed

Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas. Adv Radiat Oncol. 2017 Jan-Mar; 2(1):85-93.
View in: PubMed

Radiologic-pathologic correlation of response to chemoradiation in resectable locally advanced NSCLC. Lung Cancer. 2016 12; 102:1-8.
View in: PubMed

Inter-scan and inter-observer tumour volume delineation variability on cone beam computed tomography in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. J Med Imaging Radiat Oncol. 2017 Feb; 61(1):93-98.
View in: PubMed

Defining the role of radiotherapy for retroperitoneal sarcoma. Lancet Oncol. 2016 07; 17(7):857-859.
View in: PubMed

Role of Imaging in Management of Desmoid-type Fibromatosis: A Primer for Radiologists. Radiographics. 2016 May-Jun; 36(3):767-82.
View in: PubMed

Advanced nodal stage predicts venous thromboembolism in patients with locally advanced non-small cell lung cancer. Lung Cancer. 2016 06; 96:41-7.
View in: PubMed

Radiation Therapy for Soft-Tissue Sarcomas: A Primer for Radiologists. Radiographics. 2016 Mar-Apr; 36(2):554-72.
View in: PubMed

Does CT-based Rigidity Analysis Influence Clinical Decision-making in Simulations of Metastatic Bone Disease? Clin Orthop Relat Res. 2016 Mar; 474(3):652-9.
View in: PubMed

Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies. Radiother Oncol. 2016 Apr; 119(1):14-21.
View in: PubMed

Acute gastrointestinal toxicity and bowel bag dose-volume parameters for preoperative radiation therapy for retroperitoneal sarcoma. Pract Radiat Oncol. 2016 Sep-Oct; 6(5):360-366.
View in: PubMed

PAPILLARY THYROID CANCER IS CHARACTERIZED BY ALTERED EXPRESSION OF GENES INVOLVED IN THE SUMOYLATION PROCESS. J Biol Regul Homeost Agents. 2015 Jul-Sep; 29(3):655-62.
View in: PubMed

Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel. Int J Radiat Oncol Biol Phys. 2015 Jul 01; 92(3):602-12.
View in: PubMed

Whole Lung Irradiation in Adults with Metastatic Ewing Sarcoma: Practice Patterns and Implications for Treatment. Sarcoma. 2015; 2015:591698.
View in: PubMed

Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists. Ann Surg Oncol. 2015 Sep; 22(9):2846-52.
View in: PubMed

Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):1053-1059.
View in: PubMed

Postoperative radiation therapy for osseous metastasis: Outcomes and predictors of local failure. Pract Radiat Oncol. 2015 Sep-Oct; 5(5):e531-e536.
View in: PubMed

Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2015 May; 149(5):1374-81.
View in: PubMed

High-dose-rate Interstitial Brachytherapy Boost with a Pedicled Latissimus Dorsi Myocutaneous Flap for Myxofibrosarcoma of the Arm. Plast Reconstr Surg Glob Open. 2014 Oct; 2(10):e229.
View in: PubMed

Safety and efficacy of radiation dose delivered via iodine-125 brachytherapy mesh implantation for deep cavity sarcomas. Ann Surg Oncol. 2015 May; 22(5):1455-63.
View in: PubMed

Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer. Clin Lung Cancer. 2015 Jan; 16(1):24-32.
View in: PubMed

Role of post-operative radiation boost for soft tissue sarcomas with positive margins following pre-operative radiation and surgery. J Surg Oncol. 2014 Dec; 110(7):817-22.
View in: PubMed

Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival. Lung Cancer. 2014 Aug; 85(2):239-44.
View in: PubMed

Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):880-7.
View in: PubMed

Radiation therapy for extremity soft tissue sarcoma: in the absence of a clear survival benefit, why do we give it? Ann Surg Oncol. 2014 Aug; 21(8):2463-5.
View in: PubMed

Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry. PLoS One. 2014; 9(4):e94859.
View in: PubMed

Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma. J Clin Oncol. 2013 Dec 20; 31(36):4544-9.
View in: PubMed

Comparison of once and twice daily radiotherapy for limited stage small-cell lung cancer. Lung. 2014 Feb; 192(1):151-8.
View in: PubMed

Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery. J Am Coll Surg. 2014 Feb; 218(2):206-17.
View in: PubMed

Clinical indications and results after chest wall resection for recurrent mesothelioma. J Thorac Cardiovasc Surg. 2013 Dec; 146(6):1373-9; discussion 1379-80.
View in: PubMed

Paratesticular liposarcoma: unusual patterns of recurrence and importance of margins. Ann Surg Oncol. 2013 Jul; 20(7):2148-55.
View in: PubMed

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin. Br J Cancer. 2013 Apr 30; 108(8):1695-703.
View in: PubMed

Agreement among RTOG sarcoma radiation oncologists in contouring suspicious peritumoral edema for preoperative radiation therapy of soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys. 2013 Jun 01; 86(2):298-303.
View in: PubMed

Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. J Thorac Cardiovasc Surg. 2013 Apr; 145(4):955-963.
View in: PubMed

The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg. 2013 Apr; 145(4):909-910.
View in: PubMed

Locoregional recurrence after preoperative radiation therapy for retroperitoneal sarcoma: adverse impact of multifocal disease and potential implications of dose escalation. Ann Surg Oncol. 2013 Jul; 20(7):2140-7.
View in: PubMed

Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface. Ann Surg Oncol. 2013 May; 20(5):1494-9.
View in: PubMed

Diagnostic utility of thyroglobulin measurement in the fine needle aspirates from cervical lymph nodes: a case report. G Chir. 2012 Nov-Dec; 33(11-12):387-91.
View in: PubMed

Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy. Ann Surg Oncol. 2012 Nov; 19(12):3801-8.
View in: PubMed

TU-E-BRB-02: A Decision Support Tool for SBRT Planning Using a Searchable DVH Database. Med Phys. 2012 Jun; 39(6Part24):3908.
View in: PubMed

Cardiac angiosarcoma management and outcomes: 20-year single-institution experience. Ann Surg Oncol. 2012 Aug; 19(8):2707-15.
View in: PubMed

Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST). Br J Cancer. 2012 Feb 14; 106(4):658-65.
View in: PubMed

Surgical strategies in patients with medullary thyroid carcinoma. Clin Ter. 2012; 163(5):e303-6.
View in: PubMed

Total dural irradiation: RapidArc versus static-field IMRT: a case study. Med Dosim. 2012; 37(2):175-81.
View in: PubMed

Outcomes after combined modality therapy for EGFR-mutant and wild-type locally advanced NSCLC. Oncologist. 2011; 16(6):886-95.
View in: PubMed

High rates of histopathologic discordance in sarcoma with implications for clinical care. J Clin Oncol. 2011 May 20; 29(15_suppl):10065.
View in: PubMed

[The use of cardiac markers bed test in acute coronary syndrome in emergency department]. Clin Ter. 2011; 162(1):7-10.
View in: PubMed

Recurrence patterns and survival for patients with intermediate- and high-grade myxofibrosarcoma. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):361-7.
View in: PubMed

Management of adult soft-tissue sarcoma of the extremities and trunk. Expert Rev Anticancer Ther. 2010 Feb; 10(2):233-48.
View in: PubMed

[The role of D-dimer in aortic dissection]. Clin Ter. 2010; 161(1):45-8.
View in: PubMed

Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. Cancer. 2009 Sep 15; 115(18):4156-66.
View in: PubMed

Radiation therapy options for malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009; 21(2):159-63.
View in: PubMed

Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review. Ear Nose Throat J. 2008 Nov; 87(11):634-43.
View in: PubMed

Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience. Cancer. 2008 Mar 01; 112(5):1106-13.
View in: PubMed

Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group. Ann Oncol. 2008 Feb; 19(2):299-307.
View in: PubMed

Leiomyosarcoma of the inferior vena cava: survival after aggressive management. Ann Surg Oncol. 2007 Dec; 14(12):3534-41.
View in: PubMed

Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1366-74.
View in: PubMed

Sentinel lymph node mapping: detection of micrometastases by polymerase chain reaction in non-small cell lung cancer. J Thorac Oncol. 2007 May; 2(5 Suppl):S37.
View in: PubMed

Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys. 2006 Jul 01; 65(3):640-5.
View in: PubMed

The influence of radiotherapy technique and dose on the patterns of failure for mesothelioma patients following extrapleural pneumonectomy. J Clin Oncol. 2006 Jun 20; 24(18_suppl):7094.
View in: PubMed

Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II study. Br J Cancer. 2006 May 08; 94(9):1263-6.
View in: PubMed

Women and lung cancer. Ann Oncol. 2006 Mar; 17 Suppl 2:ii79-82.
View in: PubMed

High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol. 2005 Mar 01; 23(7):1530-7.
View in: PubMed

Patterns of failure following surgical resection for malignant pleural mesothelioma. Thorac Surg Clin. 2004 Nov; 14(4):567-73.
View in: PubMed

External beam radiation therapy for the treatment of pleural mesothelioma. Thorac Surg Clin. 2004 Nov; 14(4):543-8.
View in: PubMed

High risk of brain metastases in surgically staged IIIA NSCLC patients treated with surgery, chemotherapy and radiation. J Clin Oncol. 2004 Jul 15; 22(14_suppl):7173.
View in: PubMed

Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safety. Br J Cancer. 2004 Jul 05; 91(1):45-9.
View in: PubMed

Prospective study of palliative hypofractionated radiotherapy (8.5 Gy x 2) for patients with symptomatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1098-105.
View in: PubMed

Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer. Ann Oncol. 2003 Feb; 14(2):227-32.
View in: PubMed

Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2002 Feb 01; 52(2):406-14.
View in: PubMed

Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC). Br J Cancer. 2001 Nov 16; 85(10):1452-5.
View in: PubMed

Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma. Ann Surg. 2001 Aug; 234(2):215-23.
View in: PubMed

Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study. Breast Cancer Res Treat. 2001 Jul; 68(2):171-9.
View in: PubMed

A technique for optimization of digitally reconstructed radiographs of the chest in virtual simulation. Int J Radiat Oncol Biol Phys. 2001 Jan 01; 49(1):231-9.
View in: PubMed

Management of soft-tissue sarcomas: an overview and update. Lancet Oncol. 2000 Oct; 1:75-85.
View in: PubMed

Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study. Semin Oncol. 2000 Feb; 27(1 Suppl 1):28-32.
View in: PubMed

Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. J Clin Oncol. 1999 Oct; 17(10):3252-9.
View in: PubMed

Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome. Ann Surg. 1999 Jul; 230(1):79-86.
View in: PubMed

Cyclin-D1 expression in node-positive (N+) and node-negative (N-) infiltrating human mammary carcinomas. Int J Cancer. 1999 Apr 20; 84(2):139-44.
View in: PubMed

Patterns of recurrence and outcome for patients with clinical stage II non-small-cell lung cancer. Am J Clin Oncol. 1999 Feb; 22(1):8-14.
View in: PubMed

Orthotopic liver transplantation with and without peritoneal drainage: a comparative study. Transplant Proc. 1999 Feb-Mar; 31(1-2):556-7.
View in: PubMed

Prognostic value of crossmatch in liver transplantation. Transplant Proc. 1999 Feb-Mar; 31(1-2):552-3.
View in: PubMed

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999 Jan; 117(1):54-63; discussion 63-5.
View in: PubMed

Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers. Eur J Cancer. 1998 Oct; 34(11):1701-4.
View in: PubMed

Outcome of laparoscopic transabdominal preperitoneal inguinal hernia repair. Surg Laparosc Endosc. 1998 Jun; 8(3):223-6.
View in: PubMed

Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation. Transplant Proc. 1998 Jun; 30(4):1394-6.
View in: PubMed

Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP). Br J Cancer. 1998 Jun; 77(12):2367-70.
View in: PubMed

Epirubicin/vinorelbine as first line therapy in metastatic breast cancer. Breast Cancer Res Treat. 1998 May; 49(2):129-34.
View in: PubMed

Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer. 1998 Mar 01; 82(5):842-50.
View in: PubMed

Women and lung cancer: waiting to exhale. Chest. 1997 Oct; 112(4 Suppl):229S-234S.
View in: PubMed

A randomized trial of chemotherapy with or without estrogenic recruitment in locally advanced breast cancer. North-West Oncology Group (GONO) Study, Italy. Tumori. 1997 Sep-Oct; 83(5):829-33.
View in: PubMed

Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer. J Clin Oncol. 1997 Jul; 15(7):2510-7.
View in: PubMed

Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC). Lung Cancer. 1997 May; 17(1):147-61.
View in: PubMed

Filgrastim and lack of support of intensive adjuvant chemotherapy for high-risk breast cancer patients. Am J Clin Oncol. 1997 Apr; 20(2):169-72.
View in: PubMed

Palliative radiation therapy for non-small cell lung cancer. Hematol Oncol Clin North Am. 1997 Apr; 11(2):303-19.
View in: PubMed

Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg. 1997 Feb; 63(2):334-8.
View in: PubMed

Absence of initial viral replication and long-term high dose immunoglobulin administration improve results of hepatitis B virus recurrence prophylaxis after liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):517-8.
View in: PubMed

[Hepatic resection and transplantation for hepatocellular carcinoma in patients with cirrhosis]. Gastroenterol Clin Biol. 1997; 21(8-9):590-5.
View in: PubMed

Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancer. Am J Clin Oncol. 1996 Dec; 19(6):592-4.
View in: PubMed

Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients. Semin Oncol. 1996 Oct; 23(5 Suppl 11):38-40.
View in: PubMed

Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: a phase II study. Ann Oncol. 1996 Oct; 7(8):857-60.
View in: PubMed

A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer. Semin Oncol. 1996 Oct; 23(5 Suppl 11):28-31.
View in: PubMed

Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer. Ann Oncol. 1996 Sep; 7(7):747-9.
View in: PubMed

A pilot study with cisplatin, ifosfamide and weekly administration of vinorelbine as an outpatient combination chemotherapy for advanced non small cell lung cancer. Anticancer Res. 1996 Sep-Oct; 16(5B):3213-5.
View in: PubMed

Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO). Ann Oncol. 1996 Jul; 7(5):487-90.
View in: PubMed

Effects of primary chemotherapy on biological parameters of locally advanced breast cancer. Ann N Y Acad Sci. 1996 Apr 30; 784:419-26.
View in: PubMed

Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol. 1996 Apr; 14(4):1201-8.
View in: PubMed

Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force. Br J Cancer. 1995 Jan; 71(1):115-9.
View in: PubMed

Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: a phase II study in stage IIIB-IV non-small cell lung cancer. Semin Oncol. 1994 Jun; 21(3 Suppl 4):12-5.
View in: PubMed

Biologic and clinical effects of continuous infusion interleukin-2 in patients with non-small cell lung cancer. Cancer. 1994 Mar 01; 73(5):1353-60.
View in: PubMed

Recurrence of hepatitis C virus after liver transplantation. Transpl Int. 1994; 7 Suppl 1:S224-6.
View in: PubMed

Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMF. Anticancer Res. 1992 Sep-Oct; 12(5):1555-8.
View in: PubMed

Combination chemotherapy and interferon alpha 2b in the treatment of advanced non-small-cell lung cancer. The Italian Lung Cancer Task Force (FONICAP). Am J Clin Oncol. 1991 Apr; 14(2):120-3.
View in: PubMed

Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results. Anticancer Res. 1991 Mar-Apr; 11(2):681-4.
View in: PubMed

Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapy. J Chemother. 1990 Oct; 2(5):336-9.
View in: PubMed

Clinical evaluation of CA 15.3 in the post-operative follow-up of breast cancer patients. Int J Biol Markers. 1990 Jan-Mar; 5(1):22-6.
View in: PubMed

Accelerated chemotherapy with or without GM-CSF for small cell lung cancer: a non-randomised pilot study. Eur J Cancer. 1990; 26(9):937-41.
View in: PubMed

[Clinical testing of the validity of a treatment with a base of adrenal cortex extract in combination with hematoporphyrin and vitamin factors in some adynamic syndromes]. Clin Ter. 1969 Sep 15; 50(5):427-36.
View in: PubMed

Research Departments:

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions

Ratings

Top